Table 8.
Outcome | Cholesterol rich diet | Omega-3-rich diet | Fasting | Exercise | Electroacupuncture | Environmental enhancement |
---|---|---|---|---|---|---|
Increased viability of OPC and/or OLG | ✓✓✓ | ✓ | ||||
Preserved quantity, function, or integrity of neurons/axons | ✓ | ✓✓ | ✓ | ✓ | ||
Protected against myelin loss and/or atrophy and lesions | ✓✓✓ | ✓ | ✓ | ✓✓ | ✓ | |
Reduced CNS oxidative stress, apoptosis, or cellular dysfunction | ✓ | |||||
Stimulated the production of neurotrophins and growth factors | ✓ | ✓✓✓ | ✓ | |||
Suppressed inflammatory micro-glial and/or astrocyte activation | ✓ | ✓✓ | ✓✓✓✓ | ✓ | ||
Promoted NPC/OPC proliferation or differentiation | ✓ | ✓✓ | ✓ | ✓ | ||
Induced migration and recruitment of NPC/OPC | ✓ | |||||
Induced formation of new myelin | ✓ | ✓✓ | ✓ | |||
Increased clearance of axonal myelin debris | ✓ | ✓ | ✓ | |||
Improved neurological function (physical or cognitive) | ✓ | ✓✓✓ | ✓ | ✓✓✓ | ✓✓✓ | ✓ |
Relevant miscellaneous effect | Metabolized and incorporated into brain biochemicals | |||||
Animal models/clinical studies | Cuprizone, LPC, and EAE | Cuprizone | EAE, EtBr, cuprizone, and pilot trial | Cuprizone and LPC | Cuprizone, EtBr, and EAE | Cuprizone |
EAE: experimental autoimmune encephalomyelitis; EtBr: ethidium bromide; LPC: lysophosphatidylcholine; NPC: neural precursor cell; OLG: oligodendrocyte; OPC: oligodendrocyte precursor cell.
Each check (✓) represents an observed outcome from an individual study.